Pitt-UPMC Scientists Are Inventing mRNA Vaccine to Cure Liver Failure
Today, the only cure for end-stage liver disease is an organ transplant – an expensive treatment, the demand for...
medicine focused on developing and delivering
therapies that reestablish tissue and organ function
impaired by disease, trauma or congenital abnormalities.
GENE THERAPY
Phase I Clinical Trial Next Step
TRANSPLANTATION
Mimicking Cancer to Avoid Transplant Rejection
Introduction to The McGowan Institute
To provide a national center of expertise in regenerative medicine.
Watch Our Video
Research Spotlight
Injection of Light-Sensitive Proteins Restores Blind Man’s Vision.
Read more
Featured News
Gamifying Vision: How Mobile Gaming Is Tracking Vision Degradation in Patients
Allison Proffitt, for Bio-IT World, recently reported how innovative vision restoration/care and video gaming have merged. Her article features...
Kozai Lab Student Receives NIH F99/K00 Pre-To-Postdoc Award to Improve Brain Implants
Steven Wellman, a bioengineering PhD candidate at the University of Pittsburgh, received a Predoctoral to Postdoctoral Fellow Transition Award...
Modeling Women’s Health After Childbirth
Childbirth is a momentous and fraught time. For women, childbirth is one of the most significant biomechanical events in...
Video: Hope vs. Hype of Stem Cell Therapy
